Perspectives

Bevacizumab for Off-label Ophthalmic Use

The recent ruling (21 November 2018) of the European Court of Justice puts an end to the dispute over the off-label use of bevacizumab for age-related macular degeneration.

[more]
Archive

Focus on

Vitamin D: An important ally?
Vitamin D is commonly referred to as a group of hormone function secosteroids, of which the metabolically active form is 1,25-OH.1 Vitamin D is one of the drugs that has undergone the largest increase in prescription in recent years in Italy, rising from 6.2% in 2013 to 12.6% in 2017.2 The...
[more]
Archive

Columns

Phytovigilance & Supplements
The use of alternative and complementary medicines in breastfeeding: the HaBIT study
In recent years there has been an increase in the use of complementary and alternative medicines (CAM) in the general population, in paediatrics and also during pregnancy and lactation. This phenomenon is largely due to the fact that complementary medicine practices and even more natural products...
[more]
Archive

From regulatory agencies

16 October 2019 FDA
2019 Biologics Recalls
16 October 2019 FDA
Important Drug Information - Humate-P [Antihemophilic Factor/von Willebrand Factor Complex (Human)]
15 October 2019 FDA
Viatrexx Bio Incorporated Issues Voluntary Nationwide Recall of Sterile Injectables due to a Lack of Sterility Assurance
10 October 2019 FDA
Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of all Sterile Compounded Drug Products Due to a Lack of Sterility Assurance
08 October 2019 FDA
2019 Medical Device Recalls
08 October 2019 CADTH
New at CADTH — October 2019
08 October 2019 FDA
ICU Medical Issues a Voluntary Nationwide Recall of Certain Lots of Plum and Sapphire Microbore Infusion Sets with Inline Filters
08 October 2019 FDA
Medtronic Recalls 6 French Sherpa NX Active Guide Catheters Due to Separation and Fragmentation Issue
04 October 2019 FDA
Lung Injury Update: FDA Warns Public to Stop Using Tetrahydrocannabinol (THC)-Containing Vaping Products and Any Vaping Products Obtained Off the Street
02 October 2019 FDA
CBER FY 2018 Recall Postings
Link